These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28594891)

  • 41. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh.
    Khan IA; Khan AI; Rahman A; Siddique SA; Islam MT; Bhuiyan MAI; Chowdhury AI; Saha NC; Biswas PK; Saha A; Chowdhury F; Clemens JD; Qadri F
    Glob Health Action; 2019; 12(1):1574544. PubMed ID: 30764750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.
    Khan AI; Islam MT; Siddique SA; Ahmed S; Sheikh N; Siddik AU; Islam MS; Qadri F
    Hum Vaccin Immunother; 2019; 15(12):2882-2886. PubMed ID: 31441679
    [No Abstract]   [Full Text] [Related]  

  • 44. Coverage survey and lessons learned from a pre-emptive cholera vaccination campaign in urban and rural communities affected by landslides and floods in Freetown Sierra Leone.
    Gelormini M; Gripenberg M; Marke D; Murray M; Yambasu S; Koblo Kamara M; Michael Thomas C; Donald Sonne K; Sang S; Kayita J; Pezzoli L; Caleo G
    Vaccine; 2023 Mar; 41(14):2397-2403. PubMed ID: 36872143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
    Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
    Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
    Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.
    Poncin M; Zulu G; Voute C; Ferreras E; Muleya CM; Malama K; Pezzoli L; Mufunda J; Robert H; Uzzeni F; Luquero FJ; Chizema E; Ciglenecki I
    Bull World Health Organ; 2018 Feb; 96(2):86-93. PubMed ID: 29403111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.
    Date KA; Vicari A; Hyde TB; Mintz E; Danovaro-Holliday MC; Henry A; Tappero JW; Roels TH; Abrams J; Burkholder BT; Ruiz-Matus C; Andrus J; Dietz V
    Emerg Infect Dis; 2011 Nov; 17(11):2105-12. PubMed ID: 22099114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study.
    Leung T; Eaton J; Matrajt L
    PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010358. PubMed ID: 35442958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Global oral cholera vaccine use, 2013-2018.
    Pezzoli L;
    Vaccine; 2020 Feb; 38 Suppl 1(Suppl 1):A132-A140. PubMed ID: 31519444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
    Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
    N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "It depends how one understands it:" a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia.
    Heyerdahl LW; Pugliese-Garcia M; Nkwemu S; Tembo T; Mwamba C; Demolis R; Chilengi R; Gessner BD; Guillermet E; Sharma A
    BMC Infect Dis; 2019 May; 19(1):421. PubMed ID: 31088376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey.
    Ngwa MC; Alemu W; Okudo I; Owili C; Ugochukwu U; Clement P; Devaux I; Pezzoli L; Oche JA; Ihekweazu C; Sack DA
    BMJ Glob Health; 2020 Jun; 5(6):. PubMed ID: 32601092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.
    Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Tauheed I; Ahmed T; Ferdous J; Dash P; Basher SR; Hakim A; Lynch J; Kim JH; Excler JL; Kim DR; Clemens JD; Qadri F
    Vaccine; 2020 Feb; 38(7):1753-1761. PubMed ID: 31879124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
    PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
    Qadri F; Ali M; Lynch J; Chowdhury F; Khan AI; Wierzba TF; Excler JL; Saha A; Islam MT; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Khan IA; Kabir A; Riaz BK; Akter A; Khan A; Asaduzzaman M; Kim DR; Siddik AU; Saha NC; Cravioto A; Singh AP; Clemens JD
    Lancet Infect Dis; 2018 Jun; 18(6):666-674. PubMed ID: 29550406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.
    Lee EC; Chao DL; Lemaitre JC; Matrajt L; Pasetto D; Perez-Saez J; Finger F; Rinaldo A; Sugimoto JD; Halloran ME; Longini IM; Ternier R; Vissieres K; Azman AS; Lessler J; Ivers LC
    Lancet Glob Health; 2020 Aug; 8(8):e1081-e1089. PubMed ID: 32710864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 2013.
    Tohme RA; François J; Wannemuehler K; Iyengar P; Dismer A; Adrien P; Hyde TB; Marston BJ; Date K; Mintz E; Katz MA
    Emerg Infect Dis; 2015 Jun; 21(6):984-91. PubMed ID: 25988350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.
    Ali M; Debes AK; Luquero FJ; Kim DR; Park JY; Digilio L; Manna B; Kanungo S; Dutta S; Sur D; Bhattacharya SK; Sack DA
    PLoS Med; 2016 Sep; 13(9):e1002120. PubMed ID: 27622507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.